Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Alexander JH, Harrington RA, Tuttle RH, Berdan LG, Lincoff AM, Deckers JW, Simoons ML, Guerci A, Hochman JS, Wilcox RG, Kitt MM, Eisenberg PR, Califf RM, Topol EJ, Karsh K, Ruzyllo W, Stepinska J, Widimsky P, Boland JB, Armstrong PW. Alexander JH, et al. Among authors: hochman js. Am J Cardiol. 1999 Apr 15;83(8):1147-51. doi: 10.1016/s0002-9149(99)00049-1. Am J Cardiol. 1999. PMID: 10215274 Clinical Trial.
Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.
Steinberg JS, Hochman JS, Morgan CD, Dorian P, Naylor CD, Theroux P, Topol EJ, Armstrong PW. Steinberg JS, et al. Among authors: hochman js. Circulation. 1994 Aug;90(2):746-52. doi: 10.1161/01.cir.90.2.746. Circulation. 1994. PMID: 8044943 Clinical Trial.
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia.
Borzak S, Cannon CP, Kraft PL, Douthat L, Becker RC, Palmeri ST, Henry T, Hochman JS, Fuchs J, Antman EM, McCabe C, Braunwald E. Borzak S, et al. Among authors: hochman js. Am J Cardiol. 1998 Mar 15;81(6):678-81. doi: 10.1016/s0002-9149(97)01006-0. Am J Cardiol. 1998. PMID: 9527073 Clinical Trial.
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.
Hasdai D, Holmes DR Jr, Topol EJ, Berger PB, Criger DA, Hochman JS, Bates ER, Vahanian A, Armstrong PW, Wilcox R, Ohman EM, Califf RM. Hasdai D, et al. Among authors: hochman js. Eur Heart J. 1999 Jan;20(2):128-35. doi: 10.1053/euhj.1999.1282. Eur Heart J. 1999. PMID: 10099909 Clinical Trial.
A new regimen for heparin use in acute coronary syndromes.
Hochman JS, Wali AU, Gavrila D, Sim MJ, Malhotra S, Palazzo AM, De La Fuente B. Hochman JS, et al. Am Heart J. 1999 Aug;138(2 Pt 1):313-8. doi: 10.1016/s0002-8703(99)70118-3. Am Heart J. 1999. PMID: 10426845 Clinical Trial.
Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.
Hasdai D, Califf RM, Thompson TD, Hochman JS, Ohman EM, Pfisterer M, Bates ER, Vahanian A, Armstrong PW, Criger DA, Topol EJ, Holmes DR Jr. Hasdai D, et al. Among authors: hochman js. J Am Coll Cardiol. 2000 Jan;35(1):136-43. doi: 10.1016/s0735-1097(99)00508-2. J Am Coll Cardiol. 2000. PMID: 10636271 Free article. Clinical Trial.
454 results